Sarah Yoon

Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

USO1 isoforms differentially promote liver cancer progression by dysregulating the ER-Golgi network.

USO1 isoforms differentially promote liver cancer progression by dysregulating the ER-Golgi network.

Journal: Carcinogenesis
Published: March 16, 2021

Endoplasmic Reticulum Stress Induces CAP2 Expression Promoting Epithelial-Mesenchymal Transition in Liver Cancer Cells.

Endoplasmic Reticulum Stress Induces CAP2 Expression Promoting Epithelial-Mesenchymal Transition in Liver Cancer Cells.

Journal: Molecules and cells
Published: February 03, 2021

TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659.

TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 10, 2021

YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior.

YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior.

Journal: Experimental & molecular medicine
Published: December 08, 2020

Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.

Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.

Journal: Cancer research
Published: March 29, 2019

EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.

EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.

Journal: Experimental & molecular medicine
Published: October 17, 2018

Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.

Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.

Journal: Oncogene
Published: November 29, 2017

Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.

Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.

Journal: Nature communications
Published: February 20, 2017

Activated Rac1 regulates the degradation of IκBα and the nuclear translocation of STAT3-NFκB complexes in starved cancer cells.

Activated Rac1 regulates the degradation of IκBα and the nuclear translocation of STAT3-NFκB complexes in starved cancer cells.

Journal: Experimental & molecular medicine
Published: November 09, 2015

Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications.

Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications.

Journal: Oncotarget
Published: May 27, 2015

Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.

Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.

Journal: Gastroenterology
Published: March 27, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026